海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
334件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- A 24-week, double-blind, double-dummy, randomized, parallel-group study to investigate the effects of rosiglitazone (extended release tablets), donepezil, and placebo as monotherapy on cognition and overall clinical response in APOE e4-stratified subjects with mild to moderate Alzheimer’s disease. (REFLECT-1)
- Mild to Moderate Alzheimer's Disease MedDRA version: 8.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease
- Austria, Bulgaria, Estonia, Germany, Greece, Hungary, United Kingdom
- 2006-11-23
Authorised
- A single centre, randomised, single (patient) blind, single dose, parallel group exploratory study to compare the efficacy of an 8.75mg flurbiprofen lozenge (Strefen) with a 3mg benzydamine lozenge (Difflam) following oral administration in 200 subjects with sore throat. - Comparator study of Strefen and Difflam
- Sore throat suitable for treatment in an OTC setting.
- United Kingdom
- 2005-10-06
Authorised
- Vicriviroc in Combination Treatment with an Optimized ART Regimen in HIV-Infected Treatment-Experienced Subjects (VICTOR-E4) - VICTOR-E4
- HIV infection (R5 tropism only) with previous therapy MedDRA version: 9.1 Level: LLT Classification code 10200172 Term:
- France, Germany, Italy, Portugal, Spain, United Kingdom
- 2007-06-22
Authorised
- BCR-ABL Peptide Vaccination in Normal Subjects.An investigation in normal subjects with HLA-A3 and HLA-B8, as an extension of an identical study in patients with Chronic Myeloid Leukaemia. - BCR-ABL Peptide Vaccination in Normal Subjects.
- Healthy Subjects
- United Kingdom
- 2005-07-18
Authorised
- Nicotinamide,vitamin B3, metabolic pathways in patients with early idiopathic parkinson's disease
- Idiopathic Parkinson's disease
- United Kingdom
- 2005-04-20
Authorised
- Comparaison du nicotinamide et du sevelamer hydrochloride sur le contrôle de la phosphatémie des hémodialysés chroniques - RENANIC
- Ostéodystrophie rénale MedDRA version: 9.1 Level: SOC Classification code 10028395 Term: Musculoskeletal and connective tissue disorders
- France
- 2008-09-11
Authorised
- Study to find out whether a special treatment called recombinant human parathyroid hormone 1-84 (rh PTH) can improve the bone repair and healing of bone fracture in the Charcot foot.
- Charcot osteoarthropathy MedDRA version: 17.0 Level: PT Classification code 10031173 Term: Osteoarthropathy System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- United Kingdom
- 2010-03-17
Authorised
- A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Investigate the Use of NPSP 558, a Recombinant Human Parathyroid Hormone [rhPTH(1-84)] for the Treatment of Adults with Hypoparathyroidism - Not applicable
- Hypoparathyroidism MedDRA version: 9.1 Level: LLT Classification code 10021041 Term: Hypoparathyroidism
- Belgium, Denmark, France, Hungary, Italy, Lithuania, United Kingdom
- 2008-11-14
Authorised
- An Efficacy and Safety Trial of MK-8931 in Mild to Moderate AD (EPOCH)
- mild to moderate Alzheimer's Disease MedDRA version: 15.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Australia, Austria, Belgium, Brazil, Canada, Czech Republic, Denmark, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Portugal, Spain, Turkey, United Kingdom, United States
- 2012-10-02
Authorised
- Effect of Vitamin B3 in Friedreich's ataxia
- Friedreich’s ataxia MedDRA version: 14.0 Level: PT Classification code 10017374 Term: Friedreich's ataxia System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- United Kingdom
- 2011-09-16